Deadline: 24-Jul-25
The Pfizer is seeking grant applications to support research studies that focus on generating evidence on the use of elranatamab in multiple myeloma in the real world setting.
Areas of Interest
- Projects that will be considered for Pfizer support will focus on:
- Safety and efficacy of elranatamab in the context of real-world use
- Outpatient administration of elranatamab and alternative CRS/ICANS mitigation strategies
- Impact of prior treatments (BsAb, CAR-T, ADC) on elranatamab outcomes, and wash-out period between treatments
- Infection patterns, timing, types, and management strategies including Ig replacement therapy
- Identifying clinical and biological features of refractoriness, early- or late response, relapse to elranatamab and establishing response biomarkers.
Funding Information
- Individual study grants request up to $200,000 USD will be considered, although smaller requests (around $50,000) are also encouraged.
- If there is strong scientific justification and well-supported in the budget details, applicants may request up to a maximum of $250,000 per study.
- The estimated total available budget related to this RFP is $500,000 USD.
Eligibility Criteria
- Geographic Scope: Global
- The institution and Principal Investigator (PI) must be based in one of the eligible countries noted above.
- Only organizations are eligible to receive grants, not individuals or medical practice groups (i.e., an independent group of physicians not affiliated with a hospital, academic institution, or professional society).
- If the project involves multiple departments within an institution and/or between different institutions / organizations / associations, all institutions must have a relevant role and the requesting organization must have a key role in the project.
- The PI must have a medical or postdoctoral degree (MD, PhD, or equivalent), an advanced nursing degree (BSN with a MS/PhD), or a degree in Pharmacy, Physiotherapy, or Social Work.
- The applicant must be the PI or an authorized designee of such individual (e.g., PI’s research coordinator).
- The PI must be an employee or contractor of the requesting organization.
- Requesting organization must be legally able to receive award funding directly from Pfizer Inc. They strongly recommend that applicants confirm this with their organization or institution prior to submitting an application. Grants awarded to organizations that are subsequently found to be unable to accept funding directly from Pfizer Inc. may be subject to rescission.
For more information, visit Pfizer.
